Skip to main content

Call for Papers: Thematic series on Digital Rheumatology

Digital Rheumatology

Arthritis Research & Therapy will publish a new thematic series dedicated to the topic Digital Rheumatology.

Deadline for submissions has been extended to 15th May 2021. Find out more here


  1. Authors: Johannes Knitza, Jacob Mohn, Christina Bergmann, Eleni Kampylafka, Melanie Hagen, Daniela Bohr, Harriet Morf, Elizabeth Araujo, Matthias Englbrecht, David Simon, Arnd Kleyer, Timo Meinderink, Wolfgang Vorbrüggen, Cay Benedikt von der Decken, Stefan Kleinert, Andreas Ramming…

    Content type: Research article

  2. Authors: Javier Rueda-Gotor, Raquel López-Mejías, Sara Remuzgo-Martínez, Verónica Pulito-Cueto, Alfonso Corrales, Leticia Lera-Gómez, Virginia Portilla, Íñigo González-Mazón, Ricardo Blanco, Rosa Expósito, Cristina Mata, Javier Llorca, Vanesa Hernández-Hernández, Carlos Rodríguez-Lozano, Nuria Barbarroja, Rafaela Ortega Castro…

    Content type: Research article

Join our 20th anniversary celebrations by browsing through the journal’s milestone achievements and our specially commissioned Editorial collection.


Professor Christopher Buckley, University of Birmingham and University of Oxford, UK
Professor Harris Perlman, Northwestern University, USA

Trending articles

Click here to view which articles have been shared the most in the last month.

First Author Profiles

Meet this month's featured authors!

Aims and scope

Established in 1999, Arthritis Research and Therapy is an international, open access, peer-reviewed journal, publishing original articles in the area of musculoskeletal research and therapy as well as, reviews, commentaries and reports.
A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.
Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.

Prognostic factors for progression of osteoarthritis of the hip: a systematic review

© oceandigital / FotoliaThe hip is the third joint most commonly affected by osteoarthritis (OA) and with no therapeutic cure for hip OA, predicting which patients with hip OA are more likely to show disease progression is important for healthcare professionals.  

In this systematic review, Teirlinck et al assess the existing evidence of patient, health, and diagnostic variables associated with the progression in patients with hip osteoarthritis.

Annual Journal Metrics